Terms: = Colorectal cancer AND WWTR1, ENSG00000018408, 25937, Q9GZV5, DKFZP586I1419 AND Treatment
2 results:
1. The Hippo pathway terminal effector TAZ/wwtr1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
[TBL] [Abstract] [Full Text] [Related]
2. TAZ expression as a prognostic indicator in colorectal cancer.
Yuen HF; McCrudden CM; Huang YH; Tham JM; Zhang X; Zeng Q; Zhang SD; Hong W
PLoS One; 2013; 8(1):e54211. PubMed ID: 23372686
[TBL] [Abstract] [Full Text] [Related]
